title: Caution urged over the FDA's new breakthrough designation.
authors.forename: Kevin
authors.initials: K
authors.lastname: Jiang
mesh_terms: D017277:Drug Approval / Q000331:legislation & jurisprudence / Q000379:methods*; D014481:United States; D014486:United States Food and Drug Administration / Q000458:organization & administration*